EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹43 Cr | ₹48 Cr | ₹43 Cr | ₹40 Cr | ₹42 Cr |
What is the latest Long Term Provisions ratio of EMCURE PHARMACEUTICALS ?
| Year | Long Term Provisions |
|---|---|
| Mar2026 | ₹43 Cr |
| Mar2025 | ₹48 Cr |
| Mar2024 | ₹43 Cr |
| Mar2023 | ₹40 Cr |
| Mar2022 | ₹42 Cr |
How is Long Term Provisions of EMCURE PHARMACEUTICALS Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2026 | ₹43 Cr | -10.46 | |
| Mar2025 | ₹48 Cr | 9.83 | |
| Mar2024 | ₹43 Cr | 9.21 | |
| Mar2023 | ₹40 Cr | -5.80 | |
| Mar2022 | ₹42 Cr | - | |
Compare Long Term Provisions of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹36,234.6 Cr | 0.9% | 3.1% | 46.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,716.0 Cr | -0.8% | -1.5% | 15.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,120.0 Cr | -3% | 8.3% | 52.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,038.0 Cr | -2.2% | -1.5% | 35% | Stock Analytics | |
| CIPLA | ₹110,858.0 Cr | -0.6% | -4.9% | -13% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,828.7 Cr | 0.2% | -3.9% | -11.8% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | 0.9% |
3.1% |
46.5% |
| SENSEX | -0.6% |
-4.4% |
-8.7% |
You may also like the below Video Courses